Laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity

Main Article Content

Ezequiel Fernández
Patricio Cal
Juan Mendoza
Luciano Deluca
Tomás Jakob
Andrea Caeiro
Patricia De Rosa
Gabriel Crincoli

Abstract

Background: bariatric surgery is the most effective treatment against morbid obesity. Among a variety of surgeries, Roux-en-Y gastric bypass (RYGBP) and sleeve gastrectomy (SG) are two of the mostfrequently performed. 
Objective: describe morbidity and effectiveness of RYGBP and SG in patients with body mass index (BMI) between 40 and 50 kg/m2.
Material and method: 782 SG and362 RYGBP with BMI between 40 and 50 kg/m2were included. Demographics, morbidity, mortality, need for reoperation, weight loss and resolution of comorbidities were evaluated.
Results: major morbidity was 1.67% for SG and 6.12% for RYGBP; early and late reinterventionsrate were 0.76% for SG and 3.6% for RYGBP. There was no mortality. Percentage of excess weight loss was (for SG and RYGBP respectively) 61.1% and 63.8 at 6 months, 67.9 and 76.9 at 1 year, 65.4 and 68.7 at 2 years and 63.2 and 71.2 at 3 years. Resolution of comorbidities was similar for both surgeries.
Conclusion: both SG and RYGBP were effective and safe for the treatment of morbid obesity and re- lated diseases.

Downloads

Download data is not yet available.

Article Details

How to Cite
Fernández, E., Cal, P., Mendoza, J., Deluca, L., Jakob, T., Caeiro, A., De Rosa, P., & Crincoli, G. (2021). Laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity. Revista Argentina De Cirugía, 107(3), 125–129. Retrieved from https://revista.aac.org.ar/index.php/RevArgentCirug/article/view/290
Section
Original Article

Most read articles by the same author(s)